AZD9829

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD9829, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of AZD9829 in CD123+ Hematological Malignancies [Phase 1, Phase 2]